| Anti-osteoporotic drug efficacy for periprosthetic bone loss after total hip arthroplasty: a systematic review and network meta-analysis. | 2024 | Journal of Orthopaedic Science |
| Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis. | 2024 | Frontiers in Pharmacology |
| Denosumab versus bisphosphonates for reducing fractures in postmenopausal women with osteoporosis: a meta-analysis. | 2023 | Journal of the American Board of Family Medicine |
| Effects of denosumab on bone mineral density and bone metabolism in patients with end-stage renal disease: a systematic review and meta-analysis. | 2023 | Hemodialysis International |
| The clinical effectiveness of denosumab (Prolia®) for the treatment of osteoporosis in postmenopausal women, compared to bisphosphonates, selective estrogen receptor modulators (SERM), and placebo: a systematic review and network meta-analysis. | 2023 | Calcified Tissue International |
| Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. | 2023 | Journal of Orthopaedic Surgery & Research |
| Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials. | 2023 | Therapeutic Advances in Medical Oncology |
| Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: a systematic review and meta-analysis. | 2023 | Special Care in Dentistry |
| Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials. | 2023 | European Review for Medical and Pharmacological Sciences |
| Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis. | 2023 | Reviews in Endocrine & Metabolic Disorders |
| Zoledronic acid and denosumab for periprosthetic bone mineral density loss after joint arthroplasty: a systematic review and meta-analysis of randomized controlled trials. | 2023 | Archives of Osteoporosis |
| Efficacy of the combination of teriparatide and denosumab in the treatment of postmenopausal osteoporosis: a meta-analysis. | 2022 | Frontiers in Pharmacology |
| The efficacy of denosumab in patients with rheumatoid arthritis: a systematic review and pooled analysis of randomized or matched data. | 2022 | Frontiers in Immunology |
| Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. | 2022 | BMC Musculoskeletal Disorders |
| A systematic review and meta-analysis of interventional studies of bisphosphonates and denosumab in multiple myeloma and future perspectives. | 2022 | Journal of Musculoskeletal & Neuronal Interactions |
| Unresectable clival giant cell tumor, tumor control with denosumab after relapse: a case report and systematic review of the literature. | 2022 | Journal of Pediatric Hematology/Oncology |
| Safety of denosumab versus zoledronic acid in the older adults with osteoporosis: a meta-analysis of cohort studies. | 2022 | Archives of Osteoporosis |
| Importance of time point-specific indirect treatment comparisons of osteoporosis treatments: a systematic literature review and network meta-analyses. | 2022 | Clinical Therapeutics |
| Is denosumab associated with an increased risk for infection in patients with low bone mineral density? A systematic review and meta-analysis of randomized controlled trials. | 2021 | International Journal of Rheumatic Diseases |
| Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis. | 2021 | Journal of Drug Assessment |
| Hypercalcemia following discontinuation of denosumab therapy: a systematic review. | 2021 | Bone Reports |
| Therapeutic efficacy of denosumab for rheumatoid arthritis: a systematic review and meta-analysis. | 2021 | Rheumatology Advances in Practice |
| The role of denosumab for surgical outcomes in patients with giant cell tumour of bone: a systematic review. | 2021 | Current Oncology |
| Meta-analysis of clinical trials to assess denosumab over zoledronic acid in bone metastasis. | 2021 | International Journal of Clinical Pharmacy |
| Comparison of denosumab and zoledronic acid for the treatment of solid tumors and multiple myeloma with bone metastasis: a systematic review and meta-analysis based on randomized controlled trials. | 2021 | Journal of Orthopaedic Surgery & Research |
| Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review. | 2021 | Support Care in Cancer |
| Cardiovascular safety of denosumab across multiple indications: a systematic review and meta-analysis of randomized trials. | 2021 | Journal of Bone and Mineral Research |
| Preoperative denosumab may increase the risk of local recurrence of giant-cell tumor of bone treated with curettage: a systematic review and meta-analysis. | 2021 | Journal of Cancer |
| Risk for Infections during treatment with denosumab for osteoporosis: a systematic review and meta-analysis. | 2020 | The Journal of Clinical Endocrinology & Metabolism |
| Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials. | 2020 | Osteoporosis International |
| Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. | 2020 | The Journal of Clinical Endocrinology & Metabolism |
| Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta- analysis. | 2020 | Bone |
| Denosumab for effective tumor size reduction in patients with giant cell tumors of the bone: a systematic review and meta-analysis. | 2020 | Cancer Control |
| Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis. | 2020 | Bone |
| Pre-operative denosumab is associated with higher risk of local recurrence in giant cell tumor of bone: a systematic review and meta-analysis. | 2020 | BMC Musculoskeletal Disorders |
| Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data. | 2020 | Osteoporosis International |
| Risk for infections during treatment with denosumab for osteoporosis: a systematic review and meta-analysis. | 2020 | Journal of Clinical Endocrinology and Metabolism |
| Is treatment with denosumab associated with local recurrence in patients with giant cell tumor of bone treated with curettage? A systematic review. | 2020 | Clinical Orthopaedics and Related Research |
| Denosumab versus zoledronic acid in the prevention of skeletal-related events in vulnerable cancer patients: a meta-analysis of randomized, controlled trials. | 2020 | Clinical Therapeutics |
| Bisphosphonates versus denosumab for prevention of pathological fracture in advanced cancers with bone metastasis: a meta-analysis of randomized controlled trials. | 2020 | Journal of the American Academy of Orthopaedic Surgeons, Global Research & Reviews |
| Medical management of patients after atypical femur fractures: a systematic review and recommendations from the European Calcified Tissue Society. | 2020 | The Journal of Clinical Endocrinology & Metabolism |
| Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review. | 2019 | BMC Cancer |
| Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials. | 2019 | Journal of Bone Oncology |
| Denosumab in the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. | 2019 | Drug Design, Development and Therapy |
| Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. | 2019 | Archives of Ortopaedic and Trauma Surgery |
| Comparison of denosumab and bisphosphonates in patients with osteoporosis: a meta-analysis of randomized controlled trials. | 2019 | Journal of Clinical Endocrinology and Metabolism |
| Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis. | 2019 | Archives of Osteoporosis |
